<DOC>
	<DOCNO>NCT02212522</DOCNO>
	<brief_summary>The aim study complete identification genetic factor ( G ) undertake search environmental factor ( E ) predispose type 1 diabetes ( T1D ) constitute cohort 3500 T1D patient control cohort . We use base G analysis ( whole genome genotyping do patient use method conually update Centre National de Genotype ) innovative E analysis develop follow long term objective : - Identify G E factor influence process remain beta cell ' destruction first 3 year diagnosis ( subgroup T1D patient 0-3 year diabetes duration ) ; - Identify G factor ( pharmacogenomics ) individual response insulin use effective insulin dose phenotype period 2 year ( subgroup T1D patient negative C-peptide well manage diabetes ) ; - Undertake prospective research G E risk factor `` death bed '' syndrome diabetic adolescent ; - Undertake prospective research G E risk factor incipient glomerular microangiopathy ( regule measurement microalbuminuria ) .</brief_summary>
	<brief_title>Genetic Environmental Risk Factors Type 1 Autoimmune Diabetes Its Early Complications</brief_title>
	<detailed_description>Still recognize youth stage complete beta-cell mass destruction insulin deficiency , autoimmune T1D remain source major morbidity daily life chronic angiopathic complication despite good glycemic control . T1D onset predominantly pediatric , since incidence show rapid continuous increase young European child , due unknown emerge environmental change , create major need discovery environmental field . Finding avoidable E factor allow T1D prevention whole child population . Lack infectious exposure ( `` hygiene hypothesis '' ) , virus , early nutrition , factor suspect , E cause T1D remain black box , human disease , approach systematically respect gene-environment interaction . The aim study complete identification genetic factor ( G ) undertake search environmental factor ( E ) predispose type 1 diabetes ( T1D ) constitute cohort 3500 T1D patient control cohort . We use base G analysis ( whole genome genotyping do patient use method conually update Centre National de Genotype ) innovative E analysis develop follow long term objective : - Identify G E factor influence process remain beta cell ' destruction first 3 year diagnosis ( subgroup T1D patient 0-3 year diabetes duration ) ; - Identify G factor ( pharmacogenomics ) individual response insulin use effective insulin dose phenotype period 2 year ( subgroup T1D patient negative C-peptide well manage diabetes ) ; - Undertake prospective research G E risk factor `` death bed '' syndrome diabetic adolescent ; - Undertake prospective research G E risk factor incipient glomerular microangiopathy ( regule measurement microalbuminuria ) . We propose constitute French multicentric cohort T1D patient , well phenotyped 3 data type : genetic , environmental clinical data . The data collection scheme include entry comprehensive 850 item environmental questionnaire subject full genotyping least 500,000 SNPs whole-genome sequence deployed CNG-CEA . Every 6 month , standardize clinical assessment make patient ( WEB application ensure standardization already develop ) . Personal address ( e ) collect geocoded , map environmental geographic information system ( GIS ) . With environmental modelling , high dimensionality analysis ( HDA ) constitute one main originality ISIS-DIAB approach translational research . HDA face massive mass data , data remarkable diversity ( genomic variant , environmental item questionnaire , environmental data base map patient address , space-time item , characteristic social environment , clinical phenotype etc ) . A give genotype ( define many genomic variant ) predispose T1D give environmental context ( define possibly number factor ) induce give type autoimmune process ( age onset , rate destruction , biomarkers ) . Since T1D multifactorial heterogeneous , causal factor may interact considerable number scenarii , thus platform study factor obviously interact . Without HDA , platform would leave face data . The chef d'orchestre HDA , integrate massive amount data draw network causality . Technological advance HDA develop field science , business economics ( forecast technology ) transfer biomedical research ISIS-DIAB . French strong tradition high-level math area . We design ISIS-DIAB cohort collection data feed HDA multidisciplinary data . In ISIS-DIAB program , HDA identify variable predictive value several outcome ( confine T1D causality ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Insulindependent diabetes Patients old 6 month inclusion European North African geographical origin ( defined birthplace 4 grandparent ) , purpose genetic homogeneity cohort AntiGAD , IA2 , insulin autoantibody , present first year disease evolution , criterion absolute inclusion ( low risk error ) note searched diagnosis Informed consent date voluntarily sign ( patient and/or parent ) Noninsulin dependent diabetes MODY Severe psychological problem , comorbidities could possibly invalidate informed consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Insulin-Dependent</keyword>
	<keyword>Genome-Wide Association Study</keyword>
	<keyword>Environment-Wide Association Study</keyword>
	<keyword>Predisposition</keyword>
	<keyword>Complications</keyword>
</DOC>